The University of Chicago Header Logo

Connection

Walter M. Stadler to Benzoxazoles

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Benzoxazoles.
Walter M. Stadler
Connection Strength
0.051
Benzoxazoles
  1. Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma. JCO Precis Oncol. 2022 02; 6:e2100448.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.